Nonmyeloablative Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide for Pediatric and Young Adult Patients with High-Risk Hematologic Malignancies-Reference-Cited by-同舟云学术

Nonmyeloablative Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide for Pediatric and Young Adult Patients with High-Risk Hematologic Malignancies

Published:2017-02 Issue:2 Volume:23 Page:325-332
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Klein Orly R.^ORCID,Buddenbaum Jessica^ORCID,Tucker Noah,Chen Allen R.,Gamper Christopher J.,Loeb David,Zambidis Elias,Llosa Nicolas J.,Huo Jeffrey S.,Robey Nancy,Holuba Mary Jo^ORCID,Kasamon Yvette L.,McCurdy Shannon R.,Ambinder Richard,Bolaños-Meade Javier,Luznik Leo,Fuchs Ephraim J.,Jones Richard J.,Cooke Kenneth R.,Symons Heather J.

Funder

Giant Food Children's Cancer Research Fund

National Institutes of Health/National Cancer Institute

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference47 articles.

1. HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry;Gragert;NEJM,2014

2. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide;Luznik;Biol Blood Marrow Transplant,2008

3. Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide;McCurdy;Blood,2015

4. Outcomes of nonmyeloablative HLA-haploidentical blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in older adults;Kasamon;J Clin Oncol,2015

5. Phase II study of nonmyeloablative allogeneic bone marrow transplantation for b cell lymphoma with post-transplantation rituximab and donor selection based first on non-HLA factors;Kanakry;Biol Blood Marrow Transplant,2015

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide-based regimen for prevention of graft-versus-host disease in haploidentical peripheral blood stem cell transplantation for pediatric patients with hematologic malignancies;Annals of Hematology;2024-07-10

2. A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD;Transplantation and Cellular Therapy;2024-06

3. Disease Status and Interval between Hematopoietic Cell Transplantations Predict Outcome of Pediatric Patients Who Undergo Subsequent Transplantation for Relapsed Hematologic Malignancy;Transplantation and Cellular Therapy;2024-05

4. Should posttransplant cyclophosphamide be considered standard of care for pediatric transplantation of acute leukemia?;Hematology;2023-12-08

5. Incidence, Risk Factors, Characteristics, and Outcome of Chronic Graft Versus Host Disease in Children Undergoing Haploidentical Peripheral Blood Stem Cell Transplant With Post-transplant Cyclophosphamide;Journal of Pediatric Hematology/Oncology;2023-11-20